Mylan to Buy Women’s-Health Businesses for $750 Million

Acquisition Adds to Mylan’s Position in Emerging Markets

Mylan Inc.
MYL -2.47%
has agreed to buy certain women’s health-care businesses from India’s Famy Care Ltd. for $750 million in cash, in a move that will position Mylan as a leading provider of contraceptives in emerging markets.

Mylan has partnered with Famy in developed markets including North America, Europe and Australia since 2008. Mumbai-based Famy is a producer of oral and injectable contraceptive pills and intrauterine devices, among other items.

Under the terms of the deal, which is expected to add immediately to Mylan’s per-share earnings, Famy is eligible for an additional $50 million in contingent payments based on the achievement of certain development and regulatory milestones.